CI

At a glance

ClinicalIndex Comparison Record
Phase 1Completed· 12 enrolled
Drug / intervention
Tolvaptandrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT07166887
NCT07166887Phase 1Completed
CompareCT.gov

Pharmacokinetics, Pharmacological Effects and Safety of Multi Dose of 7.5mg Tolvaptan Tablet in Healthy Male Subjects

Otsuka Beijing Research Institute·interventional·Posted Sep 10, 2025·Updated Sep 10, 2025

In Brief

A Phase 1 clinical trial evaluating Tolvaptan for Healthy Subjects. Completed, enrolled 12 participants.

Detailed Summary

pharmacokinetics, pharmacological effects and safety of multi dose of 7.5mg Tolvaptan tablet in healthy male subjects

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHealthy Subjects
Countries--
Collaborators--

Timeline

Phase 1CompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedSep 10, 2025
Enrollment StartJun 7, 2011
Primary CompletionJul 27, 2011
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 10 months ago

Interventions

Tolvaptandrug

One dose on the first day and one dose on days 3-9, for a total of eight doses.